IQVIA

IQVIA, it is the largest clinical research and information technology services company in the world. It is the largest Contract Research Organisation (CRO) for clinical trials and RWE (Real World Evidence) studies. It has been selected by the European Medicines Agency for the development of DARWIN EU, which will be the largest European clinical research network.

IQVIA is present in 100 countries, with almost 90,000 multidisciplinary employees (more than 1,300 physicians, 8,200 technologists, 4,600 data scientists, 1,900 epidemiologists, etc.), all of whom are dedicated to health technologies and data processing, the only area in which IQVIA operates. In the last five years we have carried out more than 35,000 projects.

Role of institution in the project

IQVIA will contribute in WP 4 and 5, providing Natural Language Processing services for the extraction of searchable keywords within the central repository and increase search capabilities, and OMOP services to assist in the conversion to a centralised and standardised repository.

Oscar Gil

Oscar Gil, EUCAIM project Director and Director at IQVIA Spain leading Consulting and Technology in Healthcare. He has extensive experience, more than 20 years in projects, consulting, professional services and sales in healthcare, especially in relation to digital transformation, advanced analytics (AI/ML) and IT. His main achievements include the development of the local Digital Health consulting practices of PwC and EY, leadership as CIO and CSO of the second private hospital group in Spain (Vithas Hospitals), and active participation in sectorial forums related to Digital Health.

Borja Marabini

Borja Marabini, EUCAIM project Manager and Technology Leader at IQVIA Spain, has been leading technical projects in the Health Area for more than 9 years, implementing a wide variety of platforms and systems. Specialized in healthcare interoperability, and experienced in agile working methodologies, and in creating platforms from scratch.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.